Content about Diabetic nephropathy

October 3, 2012

A drug marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly reduced blood sugar in elderly patients with Type 2 diabetes and in adults with diabetic nephropathy, according to results of three studies presented at a diabetes meeting in Berlin.

INDIANAPOLIS — A drug marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly reduced blood sugar in elderly patients with Type 2 diabetes and in adults with diabetic nephropathy, according to results of three studies presented at a diabetes meeting in Berlin.

June 24, 2011

Despite the expansion of the diabetes drug market over the past 20 years, the rate of diabetic kidney disease has become more prevalent in the United States.

NEW YORK — Despite the expansion of the diabetes drug market over the past 20 years, the rate of diabetic kidney disease has become more prevalent in the United States.

April 22, 2011

An investigational antifibrotic and anti-inflammatory drug could help treat a common complication of diabetes.

NEW YORK — An investigational antifibrotic and anti-inflammatory drug could help treat a common complication of diabetes.

Researchers at the University of California-San Diego School of Medicine, the National Institutes of Health and the Mayo Clinic found that pirfenidone potentially could treat diabetic nephropathy, a leading cause of end-stage kidney disease.

August 11, 2010

The prevalence of diabetic retinopathy, an eye disease caused by diabetes, has increased among diabetic...

WASHINGTON The prevalence of diabetic retinopathy, an eye disease caused by diabetes, has increased among diabetic adults in the United States, according to a study published in the Journal of the American Medical Association.

May 20, 2010

A commonly prescribed diabetes drug may cause a vitamin deficiency over time, a new study...

April 29, 2010

Patients with a kidney disease caused by diabetes that receive high-dose vitamin B therapy are...

NEW YORK Patients with a kidney disease caused by diabetes that receive high-dose vitamin B therapy are more likely to have decreased kidney function and an increased risk of heart attack and stroke, a new study found.